Joincare Pharmaceutical Prospers in Capital Markets

Stock Markets

Friday, October 10, 2008 21:00:53

	Joincare Pharmaceutical Prospers in Capital Markets By AMY CHEUNG Published: March 30, 2007 04:34 AM Joincare Pharmaceutical Group Industry Co Ltd, a leading mainland maker of health products, has reevaluated its market value following the recent completion of an equity investment deal and ahead of an upcoming new share issue. You are currently reading 37 words of 329 total words in this article. To continue reading this article, you must be a subscriber. Log in now. Buy this article now for $10 USD. Not a subscriber? Start your 7-day free trial now. bookmark \| digg \| Permalink \| Tell a Friend Tags for this article: EU , import , investment , EA , UBS , capital market , drug , Shenzhen	More Articles in Stock Markets > Today’s Daily Briefs E-Mail Sign up for a roundup of the day’s top stories, sent every day. RELATED ARTICLES > Jinjiang city targets capital markets TCP’s exclusive interview with Terence Ho, a partner at Ernst & Young Shanghai SSF official outlines investment plan Jinling Hotel Plans A-share Listing China Merchants Property wins approval for US$1.17b share issue Hunan Publishing to list units Pension fund may win IPO allotments

LOGIN AGRICULTURE AND FOOD AUTOMOTIVE AVIATION BANKING, FINANCE AND INSURANCE CHEMICALS CONSUMER AND RETAIL DEMOGRAPHICS EDITOR'S BLOG ENERGY HEAVY INDUSTRY INFRASTRUCTURE AND CONSTRUCTION INVESTMENT LEGAL AND REGULATORY LOGISTICS AND TRANSPORT MACROECONOMICS NATURAL RESOURCES AND COMMODITIES PHARMACEUTICALS POLITICS REAL ESTATE STOCK MARKETS TELECOMMUNICATIONS, MEDIA AND TECHNOLOGY TEXTILES TRADE ABOUT US Affiliates Contact Us HELP Privacy Policy Terms of Use

Browse by Title
1 2 3 4 5 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z